STERIS CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2010-12-20: Form 8-K; Period of report 2010-12-20; Description 8.01 Other Events; Details 8.01.
- 2010-11-03: Form 8-K; Period of report 2010-11-03; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2010-08-03: Form 8-K; Period of report 2010-07-29; Description 2.02 Results of Operations and Financial Condition; 5.07 Submission of Matters to a Vote of Security Holders; 8.01 Other Events; Details 2.02.
- 2010-07-02: Form 8-K; Period of report 2010-07-02; Description 5.04 Temporary Suspension of Trading Under Registrant's Employee Benefit Plans; Details 5.04.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2010-12-20 | 8-K | 2010-12-20 | 8.01 Other Events | 8.01 STERIS Corporation today announced that the Company has commenced shipment of its STERIS SYSTEM 1E™ Liquid Chemical Sterilant Processing System. | d8k.htm |
| 2010-11-03 | 8-K | 2010-11-03 | 2.02 Results of Operations and Financial Condition | 2.02 On November 3, 2010, STERIS issued a press release announcing financial results for its fiscal 2011 second quarter ended September 30, 2010. | d8k.htm |
| 2010-08-03 | 8-K | 2010-07-29 | 2.02 Results of Operations and Financial Condition; 5.07 Submission of Matters to a Vote of Security Holders; 8.01 Other Events | 2.02 On August 3, 2010, STERIS Corporation (“STERIS” or “Company”) issued a press release announcing financial results for its fiscal 2011 first quarter ended June 30, 2010. 5.07 At STERIS’s 2010 Annual Meeting of Shareholders (“Meeting”), held on July 29, 2010, shareholders voted on the matters described below, with the final voting results as specified below. 8.01 STERIS voluntarily submitted information regarding modifications to the Reliance™ EPS Endoscope Processing System (the “EPS System”) to the U.S. Food and Drug Administration (“FDA”). | d8k.htm |
| 2010-07-02 | 8-K | 2010-07-02 | 5.04 Temporary Suspension of Trading Under Registrant's Employee Benefit Plans | 5.04 Reference is made to the blackout period described in Item 5.04 of the Form 8-K of STERIS Corporation (the “Company”) with the Date of Report of June 4, 2010. | d8k.htm |
| 2010-06-17 | 8-K | 2010-06-04 | 5.04 Temporary Suspension of Trading Under Registrant's Employee Benefit Plans | 5.04 A blackout period will be imposed under the STERIS Corporation 401(k) Plan (“Plan”). | d8k.htm |
| 2010-05-06 | 8-K | 2010-05-06 | 2.02 Results of Operations and Financial Condition | 2.02 On May 6, 2010, STERIS issued a press release announcing financial results for the three and twelve month periods ended March 31, 2010. | d8k.htm |
| 2010-04-20 | 8-K | 2010-04-16 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 5.02 STERIS Corporation (the “Company”) and Dr. Peter A. Burke, Senior Vice President and Chief Technology Officer of the Company, have entered into an executive retention agreement, dated as of April 1, 2010 (the “ Agreement”). 8.01 On April 20, 2010, the Company issued a press release announcing that it has reached an agreement with the U.S. Food and Drug Administration (the “FDA”) on a consent decree regarding its SYSTEM 1® liquid chemical sterilization system (“SYSTEM 1®”) including a plan (the “Transition Plan”) to assist SYSTEM 1® Customers in the United States. | d8k.htm |
| 2010-04-08 | 8-K | 2010-04-06 | 8.01 Other Events | 8.01 On April 6, 2010, STERIS Corporation (the “Company”) received notification from the U.S. Food and Drug Administration (“FDA”) that the Company’s SYSTEM 1E Liquid Chemical Sterilant Processing System (“SYSTEM 1E”) had been cleared for marketing (referred to as “510(k) clearance”). | d8k.htm |
| 2010-03-08 | 8-K | 2010-03-05 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Robert H. Fields has resigned from the STERIS Corporation Board of Directors for personal reasons, effective March 5, 2010. | d8k.htm |
| 2010-02-02 | 8-K | 2010-02-02 | 2.02 Results of Operations and Financial Condition | 2.02 On February 2, 2010, STERIS issued a press release announcing financial results for its fiscal 2010 third quarter ended December 31, 2009. | d8k.htm |